DK1194575T4 - Modificeret human granulocytkolonistimulerende faktor og fremgangsmåde til fremstilling heraf - Google Patents

Modificeret human granulocytkolonistimulerende faktor og fremgangsmåde til fremstilling heraf

Info

Publication number
DK1194575T4
DK1194575T4 DK00942494T DK00942494T DK1194575T4 DK 1194575 T4 DK1194575 T4 DK 1194575T4 DK 00942494 T DK00942494 T DK 00942494T DK 00942494 T DK00942494 T DK 00942494T DK 1194575 T4 DK1194575 T4 DK 1194575T4
Authority
DK
Denmark
Prior art keywords
csf
stimulating factor
colony stimulating
modified
human granulocyte
Prior art date
Application number
DK00942494T
Other languages
Danish (da)
English (en)
Other versions
DK1194575T3 (da
Inventor
Se Chang Kwon
Sung Youb Jung
Sung Min Bae
Gwan Sun Lee
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36129291&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1194575(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of DK1194575T3 publication Critical patent/DK1194575T3/da
Application granted granted Critical
Publication of DK1194575T4 publication Critical patent/DK1194575T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00942494T 1999-07-08 2000-07-07 Modificeret human granulocytkolonistimulerende faktor og fremgangsmåde til fremstilling heraf DK1194575T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019990027418A KR100356140B1 (ko) 1999-07-08 1999-07-08 인간 과립구 콜로니 자극인자 변이체 및 이의 생산 방법
PCT/KR2000/000733 WO2001004329A1 (en) 1999-07-08 2000-07-07 Modified human granulocyte-colony stimulating factor and process for producing same

Publications (2)

Publication Number Publication Date
DK1194575T3 DK1194575T3 (da) 2005-10-17
DK1194575T4 true DK1194575T4 (da) 2009-12-07

Family

ID=36129291

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00942494T DK1194575T4 (da) 1999-07-08 2000-07-07 Modificeret human granulocytkolonistimulerende faktor og fremgangsmåde til fremstilling heraf

Country Status (16)

Country Link
US (2) US20040224393A1 (enExample)
EP (1) EP1194575B2 (enExample)
JP (1) JP2003504069A (enExample)
KR (1) KR100356140B1 (enExample)
CN (1) CN1195859C (enExample)
AT (1) ATE299187T1 (enExample)
AU (1) AU757147C (enExample)
BR (2) BRPI0012265B8 (enExample)
CA (1) CA2378543C (enExample)
DE (1) DE60021188T3 (enExample)
DK (1) DK1194575T4 (enExample)
ES (1) ES2243275T5 (enExample)
NZ (1) NZ516476A (enExample)
PT (1) PT1194575E (enExample)
RU (1) RU2232772C2 (enExample)
WO (1) WO2001004329A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6831158B2 (en) 2000-01-10 2004-12-14 Maxygen Holdings Ltd. G-CSF conjugates
IL159524A0 (en) 2001-07-11 2004-06-01 Maxygen Holdings Ltd G-csf conjugates
US7611700B2 (en) * 2002-09-09 2009-11-03 Hanall Pharmaceuticals, Co., Ltd. Protease resistant modified interferon alpha polypeptides
US8338373B2 (en) * 2003-10-24 2012-12-25 Nora Therapeutics, Inc. Method for reducing the risk of spontaneous abortion in a human female subject
EP2198875A1 (en) 2003-10-24 2010-06-23 Nora, LLC A method for reducing the likelihood of preterm labour in a subject in need thereof
US20090226397A1 (en) 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
AU2006254543A1 (en) 2005-06-01 2006-12-07 Maxygen Holdings Ltd. PEGylated G-CSF polypeptides and methods of producing same
DE102005033250A1 (de) 2005-07-15 2007-01-18 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von G-CSF
EP2274325A4 (en) * 2008-05-13 2011-05-25 Nora Therapeutics Inc ANALOGUE OF HUMAN G-CSF AND METHOD OF MANUFACTURE AND APPLICATION THEREOF
JP5657698B2 (ja) 2010-01-19 2015-01-21 ハンミ サイエンス カンパニー リミテッドＨａｎｍｉ Ｓｃｉｅｎｃｅｃｏ．，Ｌｔｄ． 持続型顆粒球コロニー刺激因子結合体の液剤
TWI600759B (zh) 2010-04-02 2017-10-01 可娜公司 藉由抑制群落刺激因子３（ｃｓｆ３）之天然反義轉錄物以治療ｃｓｆ３相關疾病
KR101831300B1 (ko) 2010-10-29 2018-02-23 한미사이언스 주식회사 재조합 대장균으로부터 인간 과립구 콜로니 자극인자를 정제하는 방법
RU2467764C2 (ru) * 2011-01-12 2012-11-27 Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Пензенский институт усовершенствования врачей" Министерства здравоохранения и социального развития Российской Федерации Способ лечения больных аутоиммунной хронической крапивницей с использованием внутривенного введения препарата "габриглобин"
KR101623906B1 (ko) 2014-07-23 2016-05-24 주식회사 이큐스앤자루 과립구 콜로니 자극인자 변이 단백질 또는 이의 트랜스페린 융합 단백질을 유효성분으로 포함하는 약학적 조성물
WO2016013725A1 (ko) * 2014-07-23 2016-01-28 주식회사 이큐스앤자루 과립구 콜로니 자극인자 변이 단백질 또는 이의 트랜스페린 융합 단백질을 유효성분으로 포함하는 약학적 조성물
KR102645064B1 (ko) 2017-02-03 2024-03-08 한미약품 주식회사 지속성이 증가된 생리활성 물질의 결합체 및 이의 용도
US11267858B2 (en) 2019-05-31 2022-03-08 Spectrum Pharmaceuticals, Inc. Methods of treatment using G-CSF protein complex
US11684655B2 (en) 2019-05-31 2023-06-27 Spectrum Pharmaceuticals, Inc. Methods of treating neutorpenia using G-CSF protein complex
KR102375269B1 (ko) * 2021-01-27 2022-03-17 한미약품 주식회사 단백질 액상 제제 및 이의 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810643A (en) * 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
JPH01500483A (ja) * 1986-08-11 1989-02-23 シタス　コーポレイション Ｇ‐ｃｓｆ及びそのミューテインの発現
US5362853A (en) * 1986-12-23 1994-11-08 Kyowa Hakko Kogyo Co., Ltd. Polypeptide derivatives of human granulocyte colony stimulating factor
US5714581A (en) * 1986-12-23 1998-02-03 Kyowa Hakko Kogyo Co., Ltd. Polypeptide derivatives of human granulocyte colony stimulating factor
JPH02104598A (ja) 1988-04-12 1990-04-17 Kirin Amgen Inc ヒト顆粒球コロニー刺激因子ポリペプチド誘導体
NZ236819A (en) 1990-02-03 1993-07-27 Max Planck Gesellschaft Enzymatic cleavage of fusion proteins; fusion proteins; recombinant dna and pharmaceutical compositions
GB9107846D0 (en) 1990-04-30 1991-05-29 Ici Plc Polypeptides
EP0626448A3 (de) 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
US6476198B1 (en) 1993-07-13 2002-11-05 The Scripps Research Institute Multispecific and multivalent antigen-binding polypeptide molecules
US5451660A (en) * 1993-12-13 1995-09-19 Genentech, Inc. Method for purifying polypeptides
EP0789776B1 (en) 1994-11-01 2001-06-13 Winfried Wels Nucleic acid transfer system
US6100070A (en) 1995-10-05 2000-08-08 G. D. Searle & Co. G-CSF receptor agonists
KR100316347B1 (ko) * 1998-09-15 2002-08-27 한미약품(주) 대장균엔테로톡신ⅱ신호펩티드의변형체와인체성장호르몬의융합단백질을발현하는재조합미생물및그를이용한인체성장호르몬의제조방법
NZ522847A (en) * 2000-05-16 2004-11-26 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues

Also Published As

Publication number Publication date
RU2232772C2 (ru) 2004-07-20
WO2001004329A1 (en) 2001-01-18
JP2003504069A (ja) 2003-02-04
KR100356140B1 (ko) 2002-10-19
ATE299187T1 (de) 2005-07-15
BRPI0012265B8 (pt) 2021-05-25
EP1194575A4 (en) 2002-10-24
DE60021188D1 (de) 2005-08-11
CN1195859C (zh) 2005-04-06
ES2243275T3 (es) 2005-12-01
KR20010009171A (ko) 2001-02-05
AU5710600A (en) 2001-01-30
CA2378543A1 (en) 2001-01-18
EP1194575A1 (en) 2002-04-10
BR0012265A (pt) 2002-03-12
ES2243275T5 (es) 2009-12-02
DK1194575T3 (da) 2005-10-17
AU757147C (en) 2005-03-03
EP1194575B1 (en) 2005-07-06
BRPI0012265B1 (pt) 2018-11-21
US20040224393A1 (en) 2004-11-11
PT1194575E (pt) 2005-10-31
NZ516476A (en) 2003-09-26
US7704709B2 (en) 2010-04-27
EP1194575B2 (en) 2009-08-26
DE60021188T2 (de) 2006-04-27
US20080064066A1 (en) 2008-03-13
DE60021188T3 (de) 2010-04-01
CN1360636A (zh) 2002-07-24
CA2378543C (en) 2010-05-18
AU757147B2 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
DK1194575T4 (da) Modificeret human granulocytkolonistimulerende faktor og fremgangsmåde til fremstilling heraf
CN101705212B (zh) N-酰基高丝氨酸内酯酶及其生产方法与专用重组菌
PL331351A1 (en) Novel strains of escherichia coli, methods of obtaining them and their application in l-treonin production fermentation processes
PT1165791E (pt) Citocina humana como ligando do receptor zalpha e seus usos
DK1317537T3 (da) Sammensætninger og fremgangsmåder med G-CSF analoger
DE69929805D1 (de) Modifiziertes e.coli enterotoxin ii signalpeptid sowie ein mikroorganismus der ein fusionsprotein sowie ein heterologes protein exprimiert
ATE118788T1 (de) Antifungisches polypeptid, verfahren zu seiner herstellung.
DE3683267D1 (de) Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung.
DE60228213D1 (de) Verfahren zur herstellung von l-aminosäuren mit stämmen der familie enterobacteriaceae in den das frur-gen deletiert worden ist
SU1720493A3 (ru) Способ получени штамма SтRертососсUS SaNGUIS, способного секретировать @ -1,3-глюкан-3-глюканогидролазу
DE59610632D1 (de) Varianten des humanen rekombinanten interferon-gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
NZ334568A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
DE69736389T8 (de) Proteine mit zellulase-aktivitäten und prozess für ihre herstellung
WO2017181920A1 (zh) 一种重组人粒细胞集落刺激因子的制备方法
MX9605082A (es) Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
Mak et al. Formulation and optimization of two culture media for the production of tumour necrosis factor‐β in Escherichia coli
IL158244A0 (en) Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same
FR2785291B1 (fr) Procede de production in vivo de proteines chimiquement diversifiees par incorporation d'acides amines non conventionnels
DE60033823D1 (de) Rekombinante mikroorganismen
SU1144376A1 (ru) Рекомбинатные плазмиды- @ - @ ,кодирующие синтез лейкоцитарного интерферона типа @ - @ человека, и штаммы @ @ / @ - @ - @ -продуценты лейкоцитарного интерферона типа @ -F человека
JPH07203975A (ja) 抗菌活性ペプチドをコードする遺伝子及び抗菌活性ペプチドの製造方法
MXPA02008010A (es) Enterotoxina estafilococica sec-ser, vector de expresion y celula huesped, metodo de produccion de los mismos y metodo de fabricacion de vacuna.
CN1030962C (zh) 龋齿预防制剂的制备方法